GCP-Certified Site
Good Clinical Practice certification granted by INVIMA in 2024 under Resolution 2378 of 2008, on top of an IPS licence issued by the Colombian Ministry of Health in 2022. Authorised to run Phase I, II, III and IV clinical studies.

Science / People / A healthier tomorrow
Connecting global sponsors and CROs with experienced investigators, diverse patient populations and clinical research capabilities in the Colombian Caribbean.
Integrated infrastructure
Samples stay inside one controlled chain of custody, from the moment they are drawn to the moment they leave the country.
Sample draw in-site, with procedure room, vaccination and apheresis capability.
Clinical laboratory and aliquoting under study-specific procedures.
Temperature-controlled storage and an institutional biobank.
Documentation and cold-chain coordination for cross-border transport.
Inside Allied







Scientific differentiator
The Colombian Caribbean is an endemic setting for arboviral disease. Our team has published on dengue and Zika vaccines, congenital Zika, neutralizing antibodies and chronic chikungunya-associated arthritis, and works across HIV, tuberculosis and hepatitis.
A research group recognised by Minciencias, Colombia's national science agency.
Therapeutic areasWhy Allied
An independent site designed around protocol execution: regulated infrastructure, a standing investigator team and the operational layer that keeps a study moving.
Good Clinical Practice certification granted by INVIMA in 2024 under Resolution 2378 of 2008, on top of an IPS licence issued by the Colombian Ministry of Health in 2022. Authorised to run Phase I, II, III and IV clinical studies.
Eleven investigators across oncology, cardiology, pulmonology, nephrology, hematology, rheumatology and infectious diseases, supported by coordinators and a research pharmacy.
Proprietary patient databases, institutional agreements with clinics such as San Ignacio and Los Almendros, and a referral network reaching beyond Atlántico, Magdalena and Bolívar into Córdoba, Sucre and La Guajira.
Clinical laboratory, investigational pharmacy, procedure room, consulting rooms, vaccination, apheresis and temperature-controlled storage under one roof.
Collection, processing, biobanking and international shipment of biological samples, with experience coordinating cross-border transport.
Send us the synopsis. We will tell you what we can realistically do.
Evidence
Peer-reviewed work from our investigators. Full reference list available on request.
Dengue · NS1 antibodies
Papa MP, Mendoza-Torres E, Sun P, et al.
The Journal of Infectious Diseases · 2024;230(6):e1226–e1234
Allied Research Society co-author: Liliana Encinales
Read articleDengue · Vaccine acceptance
McMahon E, Encinales L, Navarro Encinales C, et al.
Microorganisms · 2019;7(10):458
Allied Research Society co-authors: Liliana Encinales, Nelly Pacheco
Read articlePatient access
Barranquilla has a population of 1,327,209, and 2,199,507 across its metropolitan area (Soledad, Malambo, Galapa and Puerto Colombia). Its proximity to Santa Marta (in Magdalena) and Cartagena (in Bolívar) — sharing the same tropical climate and disease profile — extends our recruitment reach across three departments through our own databases and institutional relationships.
Recruitment reaches Atlántico, Magdalena and Bolívar from our site in Barranquilla, through our own patient databases and referral pathways with regional health institutions.

Explore our coverage in Atlántico, Magdalena and Bolívar. Select a department to learn more.
Atlántico. Home department. Barranquilla and its metropolitan area, where the site and most of our recruitment activity sit.
Magdalena. Northern reach along the Caribbean coast, accessed through institutional relationships and community outreach.
Bolívar. Southern reach of our recruitment network, including urban and peri-urban populations.
Internally maintained records that let us pre-screen against protocol criteria before a study opens.
Referral pathways with clinics and health institutions in the region.
Community outreach across urban and peri-urban populations of the Caribbean coast.
Strategic alliance
Global Disease Research (GDR) Colombia is the non-profit foundation affiliated with Allied. We run clinical research; GDR brings health care, prevention and education to the most vulnerable communities of the Colombian Caribbean.
Child, women's and community health for vulnerable populations.
Investigators, scientific training and joint publications.
A non-profit structure for grants and public health.
Network
